397 related articles for article (PubMed ID: 32617963)
21. Revealing the protective and pathogenic potential of MAIT cells.
D'Souza C; Chen Z; Corbett AJ
Mol Immunol; 2018 Nov; 103():46-54. PubMed ID: 30196233
[TBL] [Abstract][Full Text] [Related]
22. The role of invariant T cells in inflammation of the skin and airways.
Yip KH; Papadopoulos M; Pant H; Tumes DJ
Semin Immunopathol; 2019 May; 41(3):401-410. PubMed ID: 30989319
[TBL] [Abstract][Full Text] [Related]
23. Mucosal-Associated Invariant T Cells Expressing the TRAV1-TRAJ33 Chain Are Present in Pigs.
Xiao X; Li K; Ma X; Liu B; He X; Yang S; Wang W; Jiang B; Cai J
Front Immunol; 2019; 10():2070. PubMed ID: 31552029
[TBL] [Abstract][Full Text] [Related]
24. MAIT cells and MR1-antigen recognition.
Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
[TBL] [Abstract][Full Text] [Related]
25. MAIT cells in immune-mediated tissue injury and repair.
Waterhölter A; Wunderlich M; Turner JE
Eur J Immunol; 2023 Dec; 53(12):e2350483. PubMed ID: 37740567
[TBL] [Abstract][Full Text] [Related]
26. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines.
Dias J; Leeansyah E; Sandberg JK
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5434-E5443. PubMed ID: 28630305
[TBL] [Abstract][Full Text] [Related]
27. Emerging Roles of Mucosal-Associated Invariant T Cells in Rheumatology.
Li Y; Du J; Wei W
Front Immunol; 2022; 13():819992. PubMed ID: 35317168
[TBL] [Abstract][Full Text] [Related]
28. Mucosal-Associated Invariant T Cell Levels Are Reduced in the Peripheral Blood and Lungs of Children With Active Pulmonary Tuberculosis.
Malka-Ruimy C; Ben Youssef G; Lambert M; Tourret M; Ghazarian L; Faye A; Caillat-Zucman S; Houdouin V
Front Immunol; 2019; 10():206. PubMed ID: 30853958
[TBL] [Abstract][Full Text] [Related]
29. The MAIT conundrum - how human MAIT cells distinguish bacterial colonization from infection in mucosal barrier tissues.
Berkson JD; Prlic M
Immunol Lett; 2017 Dec; 192():7-11. PubMed ID: 28987476
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of mucosal-associated invariant T cells and their roles in immune diseases.
Chiba A; Murayama G; Miyake S
Int Immunol; 2021 Nov; 33(12):775-780. PubMed ID: 34508634
[TBL] [Abstract][Full Text] [Related]
31. MAIT cells: an historical and evolutionary perspective.
Lantz O; Legoux F
Immunol Cell Biol; 2018 Jul; 96(6):564-572. PubMed ID: 29363173
[TBL] [Abstract][Full Text] [Related]
32. Mucosal-associated invariant T cells in natural immunity and vaccination against infectious diseases in humans.
Masina N; Bekiswa A; Shey M
Curr Opin Immunol; 2021 Aug; 71():1-5. PubMed ID: 33773437
[TBL] [Abstract][Full Text] [Related]
33. MAIT-cells: A tailor-made mate in the ancient battle against infectious diseases?
Moreira ML; Tsuji M; Corbett AJ; Araújo MSS; Teixeira-Carvalho A; Martins-Filho OA; Peruhype-Magalhães V; Coelho-Dos-Reis JG
Immunol Lett; 2017 Jul; 187():53-60. PubMed ID: 28526582
[TBL] [Abstract][Full Text] [Related]
34. Production of IL-17 by MAIT Cells Is Increased in Multiple Sclerosis and Is Associated with IL-7 Receptor Expression.
Willing A; Jäger J; Reinhardt S; Kursawe N; Friese MA
J Immunol; 2018 Feb; 200(3):974-982. PubMed ID: 29298833
[TBL] [Abstract][Full Text] [Related]
35. Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease.
Juno JA; Waruk JLM; Wragg KM; Mesa C; Lopez C; Bueti J; Kent SJ; Ball TB; Kiazyk SA
Front Immunol; 2018; 9():1076. PubMed ID: 29868028
[TBL] [Abstract][Full Text] [Related]
36. Contribution of APCs to mucosal-associated invariant T cell activation in infectious disease and cancer.
Shey MS; Balfour A; Wilkinson KA; Meintjes G
Innate Immun; 2018 May; 24(4):192-202. PubMed ID: 29631470
[TBL] [Abstract][Full Text] [Related]
37. Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells.
Garner LC; Klenerman P; Provine NM
Front Immunol; 2018; 9():1478. PubMed ID: 30013556
[TBL] [Abstract][Full Text] [Related]
38. MAIT cells as attractive vaccine targets.
Downey AM; Kapłonek P; Seeberger PH
FEBS Lett; 2019 Jul; 593(13):1627-1640. PubMed ID: 31206659
[TBL] [Abstract][Full Text] [Related]
39. Activation, Deficiency, and Reduced IFN-γ Production of Mucosal-Associated Invariant T Cells in Patients with Inflammatory Bowel Disease.
Ju JK; Cho YN; Park KJ; Kwak HD; Jin HM; Park SY; Kim HS; Kee SJ; Park YW
J Innate Immun; 2020; 12(5):422-434. PubMed ID: 32535589
[TBL] [Abstract][Full Text] [Related]
40. IL-33 Enhances IFNγ and TNFα Production by Human MAIT Cells: A New Pro-Th1 Effect of IL-33.
Azzout M; Dietrich C; Machavoine F; Gastineau P; Bottier A; Lezmi G; Leite-de-Moraes M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
